News Outlets Continue to Report Avandia's Declining Sales, Status
http://www.healthmantra.net/articles/11320/1/News-Outlets-Continue-to-Report-Avandias-Declining-Sales-Status/Page1.html
Katie Kelley
For more information on welding rod litigation, visit http://welding-rod.legalview.com/. Also use the LegalView homepage at http://www.LegalView.com to browse other legal issues such as the the Erb's Palsy information portal or learn about the latest news regarding the Digitek digoxin recall. By Katie Kelley
Published on 10/21/2008
News agencies continue to report the decline in sales and status of the drug linked to the side effects that have occurred among Avandia patients. The drug's risks have been found to be associated with heart failure and early on-set osteopororsis.
An October 10, 2008 article from Market Watch, a part of The Wall Street Journal's digital network, published an anti-diabetics market forecast, which found that Avandia and Actos are and will continue to lose market shares and their leading marketing positions status because of unresolved safety concerns.
The article found that by 2011 Avandia, a type 2 diabetes non-insulin treatment, will see a decrease in sales because of the continued cloud of controversy shrouding the drug's effects and linking the drug to early onset osteoporosis and increased risk of heart failure among patients.
What Does Avandia Treat?
Avandia (rosiglitazone maleate) is an anti-diabetic therapy that does not use insulin and is part of the glitazone class of drugs. The drug, from GlaxoSmithKline, was released in May 1999 and has since been prescribed to millions of Americans suffering from type 2 diabetes. The drug works with the body's natural insulin to control glucose levels and ensure diabetic shock does not occur, which can be fatal among a diabetic.
In 2007, several reports and studies began to surface on the drug's dangers. One article, published in the New England Journal of Medicine linked the anti-diabetic drug to an increased risk of heart disease and heart failure among patients.
An additional study conducted by Swiss researchers found that patients consuming Avandia were more likely to suffer from bone fractures and breaks because of accelerated osteoporosis that was developing among Avandia patients and caused directly from the drug.
Avandia Risks
According to a clinical trial of the drug in which 9,900 patients were tested, the drug had an array of debilitating and uncomfortable side effects including:
* upper respiratory tract infection
* injury
* headache
* back pain
* hyperglycemia
* fatigue
* sinusitis
* diarrhea
* hypoglycemia
* onset or exacerbation of congestive heart failure
Individuals who have suffered from the severe risks of Avandia are not only encouraged to locate a medical professional immediately to assess the drug's risks, but to also consult an Avandia attorney who can provide insightful details as to building an Avandia case.
Osteoporosis and heart damage are irreversible effects caused by Avandia. These conditions will require thousands of dollars to treat during an individual's lifetime and many cannot afford costly medical bills for these diseases in addition to treating their diabetes.
An Avandia attorney may be able to develop a pharmaceutical lawsuit that will potentially earn a victim monetary compensation for the damage caused by the Avandia side effects. It is important to protect an individual effected by the serious Avandia side effects by locating an experienced pharmaceutical attorney who can provide insightful details into developing a potential class action lawsuit.
The article found that by 2011 Avandia, a type 2 diabetes non-insulin treatment, will see a decrease in sales because of the continued cloud of controversy shrouding the drug's effects and linking the drug to early onset osteoporosis and increased risk of heart failure among patients.
What Does Avandia Treat?
Avandia (rosiglitazone maleate) is an anti-diabetic therapy that does not use insulin and is part of the glitazone class of drugs. The drug, from GlaxoSmithKline, was released in May 1999 and has since been prescribed to millions of Americans suffering from type 2 diabetes. The drug works with the body's natural insulin to control glucose levels and ensure diabetic shock does not occur, which can be fatal among a diabetic.
In 2007, several reports and studies began to surface on the drug's dangers. One article, published in the New England Journal of Medicine linked the anti-diabetic drug to an increased risk of heart disease and heart failure among patients.
An additional study conducted by Swiss researchers found that patients consuming Avandia were more likely to suffer from bone fractures and breaks because of accelerated osteoporosis that was developing among Avandia patients and caused directly from the drug.
Avandia Risks
According to a clinical trial of the drug in which 9,900 patients were tested, the drug had an array of debilitating and uncomfortable side effects including:
* upper respiratory tract infection
* injury
* headache
* back pain
* hyperglycemia
* fatigue
* sinusitis
* diarrhea
* hypoglycemia
* onset or exacerbation of congestive heart failure
Individuals who have suffered from the severe risks of Avandia are not only encouraged to locate a medical professional immediately to assess the drug's risks, but to also consult an Avandia attorney who can provide insightful details as to building an Avandia case.
Osteoporosis and heart damage are irreversible effects caused by Avandia. These conditions will require thousands of dollars to treat during an individual's lifetime and many cannot afford costly medical bills for these diseases in addition to treating their diabetes.
An Avandia attorney may be able to develop a pharmaceutical lawsuit that will potentially earn a victim monetary compensation for the damage caused by the Avandia side effects. It is important to protect an individual effected by the serious Avandia side effects by locating an experienced pharmaceutical attorney who can provide insightful details into developing a potential class action lawsuit.